Member Info for Brondby

But I'm holding mine until buyout, maybe 40-50p?

After hours. Brewing up for another rise.

Ciz isn't AIM, but main market. But the outage is also affecting that.

Techtonic,

As Greend100 points out, Hardman is 18m months and we've since announced that we have met key milestones (particularly around scaling up), that allow us to proceed to clinical trials, and we have announced a $9billion partner. So Hardmans risk weighted assessment will be way out of date.

My valuation is based more on what we obsereved happen to OBD recently, adding circa 50-60m market cap after announcing the test commercialisation, despite having signposted this to the market in a previous RNS!! So there is already a precedent for the market totally ignoring a cancer test until its delivered.

Our test has at least as large a global market and is expected to be more accurate.

Currently, i would say we could easily sit at double the valuation in the current market, and then add similar to OBD on announcement of test. But the current market is very short termist, so what do i know?

That 1M share "sell" yesterday may not have been a sell. Always hard to tell for sure. MMs may have bought at 2.26 and sold them to a buyer at 2.3 with such a large transaction.

The fact I can get a dummy quote for a sell at a price higher than before that "sell", and the spread hasn't moved, is telling me there is still demand for shares.

As greend100

Yes, some good consolidation at this level. Still amazed tbh at how many low ambition 10%ers we have. I guess everyone has their reasons for selling.

On LDT being ready i can see 50-60M mc easy. I just cant see Biotechne letting this go, and any hint of an offer and this will rocket even more. Not often opportunities like this arise.

Of course there is still risk, but the potential rewards are such a few grand in here could easily turn into 100k

Meanwhile the CDT recovery will hopefully mean no more dilution; though given the numbers involved, I would not see that are a big problem in any case.

MMs went fishing for shares there. Not many picked up. Will have to move higher.

Selling some hardware, though, is one thing. With Bio-Techne'd stated M&A goals, letting ciz slip through their fingers would be approaching negligence

It's had some steady buying throughout. The difference is we had some sellers who had been trading the CDT gig, now likely mostly gone.

Those still in, know the value on offer here and so shares for that stream of buyers will be harder to come by, hence gradual move up in price.

I can't think of a share with more upside over the coming months and years. If this test works at scale, and i think ciz are very confident of that given the years of research and trials behind it, then i can't see Biotechne letting it go elsewhere. Its a matter of at what stage and at what price in my mind.

Https://audioboom.com/posts/8406202-sunday-roast-featuring-charles-archer-long-term-ftse-aim-investor-and-freelance-financial-analys

Investment case is "Looking for a buyout at huge premium", "relatively low risk".

No updates unless significant news says AS.

So settle in for the long game and wait for the traders to exit with boredom.

This is all very intriguing, and suggests a lot is going on behind the scenes that is not being RNS'd ... yet.

Woody, it still 2p only because its not commercialised and hence proven it can work at scale. But its only a matter of time IMO before we see a meteoric re-rate here.

OBD went up 50million mc on announcing its prostate test. That's around x8 for ciz!!

Is EarlofAim a bot? Just posting stuff lifted straight from twitter(X) and passing off as their own.

Ciz isnt even AIM, lol.

Are the cheap shares all gone?

Sounds illegal Jace

Sorry, I dont understand what you are suggesting is going on.

Selling doesn't seem organised enough for that. Random amounts and few rounded number sells. I'm more inclined to think its some folks seeking faster bucks elsewhere.

But time will tell. Suspect we are due something on funding soon, whether that be loan facility, cdt share sales, or external (Biotechne?) investment remains to be seen.

... that we still have a persistent seller. Let them sell for a loss. Will mean we can buy cheap.

I've picked up another few tens of thousand in small batches the last week or so around the 1.8 level.

Not bonkers Joe, deliberate.

They want your shares!

I wonder why.

Hold on folks ...